Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bb71eedb0760c0e141c07289c7ef34f92> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bb71eedb0760c0e141c07289c7ef34f92 NCIT_P378 "NCI" @default.
- Bb71eedb0760c0e141c07289c7ef34f92 type Axiom @default.
- Bb71eedb0760c0e141c07289c7ef34f92 annotatedProperty IAO_0000115 @default.
- Bb71eedb0760c0e141c07289c7ef34f92 annotatedSource NCIT_C172999 @default.
- Bb71eedb0760c0e141c07289c7ef34f92 annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with dabrafenib and trametinib in patients with tumors that have BRAF V600E or V600K substitution mutations, excluding colorectal cancer, melanoma, non-small cell lung cancer, or thyroid cancer." @default.